Iveco Group N.V. updates its 2024 Corporate Calendar 24-02-2024, 00:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

VCI Global Secures US$12 Million Contract With Datanex for AI-Powered Digital Marketing Solutions Through VC AI Limited 12-02-2025, 21:09